Sequential Method Determination of Oxycodone for Thoracoscope Surgery Median Effective Dose of Acute Pain Treatment

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorJianbo Wu

About this trial

The goal of this clinical trial is to measure the median effective dose of oxycodone for the treatment of acute pain after thoracoscopic lobectomy. This clinical trial was divided into two groups based on age, Group I (Age \< 65 years old) and Group II (Age ≥65 years old). We used the sequential allocation designed by Dixon. The initial oxycodone dose was set to 0.1 mg/kg.A satisfactory or an unsatisfactory analgesic response of the previous patient determined, respectively, the relative 10% decrease or increase in the dose of oxycodone the next patient received in the same group. The patient before the first crossover point was included as the first case for ED50 estimation in each group.The study was conducted until 7 crossover points were collected

Eligibility criteria

Qualifiers

The first unilateral thoracoscopic lobectomy was performed under general anesthesia

age 18- 80 years old

American Society of Anesthesiologists (ASA) physical status I-III

Sign the informed consent of the patients

Disqualifiers

Moderate to severe obesity (i.e., BMI > 30kg/m2)

Allergic or hypersensitive reaction to oxycodon

A history of chronic pain

Patients with significant heart, pulmonary, liver or renal disease

Trial design

Treatments tested in this trial

  • Oxycodone will be administered intravenously in the group 1

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Jianbo Wu

Lead sponsor

Qianfoshan Hospital

Sponsor institution